Germany· DE-A57-3947fb7b980c4cd0
Bimatoprost/Timolol Axunio
A medicinal product containing timolol maleate, bimatoprost, registered in Germany by Axunio Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Timolol Maleate, Bimatoprost
- Manufacturer
- Axunio Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Timolol maleate, bimatoprost in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomBimatoprost 300micrograms/ml / Timolol 5mg/ml eye dropsAlliance Healthcare (Distribution) Ltd
- NetherlandsBimatoprost/Timolol axunio 0,3 mg/ml + 5 mg/ml oogdruppels, oplossingaxunio Pharma GmbH
- SpainBAPIRI 0,3 MG + 5 MG/ML COLIRIO EN SOLUCIONBrill Pharma S.L.
- ItalyBIMATOPROST E TIMOLOLO TEVATEVA ITALIA S.R.L.
- CzechiaBIMATOPROST/TIMOLOL OLIKLAOlikla s.r.o., Kostelec nad Černými Lesy
- FinlandBimatoprost/Timolol MylanMylan AB
- FranceBIMATOPROST/TIMOLOL BIOGARAN 0,3 mg/mL + 5 mg/mL, collyre en solutionBIOGARAN
- SwitzerlandBimatoprost-Mepha Plus
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Bimatoprost/Timolol Genetic, Bimatoprost/Timolol Stada Arzneimittel Ag
- Belgium · Duelym, Ganzed
- Bulgaria · Бимасопт, Биматопрост Дуо
- Cyprus · Birmost-Co, Duelym
- Czechia · Bimatoprost/Timolol Olikla, Duelym
- Denmark · Bimatoprost/Timolol Pharmathen, Bimatoprost/Timolol Stada
- Estonia · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
- Spain · Bapiri, Bimatoprost/Timolol Stada
- Finland · Bimatoprost/Timolol Stada, Bitifrin
- France · Bimatoprost / Timolol Biogaran, Bimatoprost/Timolol Eg
- United Kingdom (Northern Ireland) · Bimatoprost + Timolol Blumont Pharma, Bimatoprost/Timolol Aspire
- Greece · Birmost-Co, Duelym
- Croatia · Duelym
- Ireland · Bitifrin, Duelym
- Iceland · Bimatoprost/Timolol Stada, Duelym
- Italy · Bimatoprost E Timololo Eg, Bimatoprost E Timololo Mylan
- Liechtenstein · Ganfort
- Lithuania · Bimatoprost/Timolol Elvim, Bimatoprost/Timolol Teva
- Luxembourg · Duelym, Ganzed
- Latvia · Bapiri, Bimatoprost/Timolol Elvim
- Netherlands · Bimatoprost/Timolol Axunio, Bimatoprost/Timolol Blumont
- Norway · Bimabloc, Bimtim
- Poland · Bimaroz Duo, Bimifree Combi
- Portugal · Eduelym, Ibrigan
- Romania · Bimatoprost/Timolol Rompharm, Duelym
- Sweden · Bimabloc, Bimatoprost/Timolol Brown & Burk
- Slovakia · Bimatoprost/Timolol Olikla, Duelym
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc3699dd-c9da-4088-b5b6-19c97bd2b2d1 GET /v1/drugs/dc3699dd-c9da-4088-b5b6-19c97bd2b2d1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Ocular Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Timolol Maleate, Bimatoprost",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about timolol maleate, bimatoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.